Home|Journals|Articles by Year

Directory for Medical Articles
 

Original Article

J Liaquat Uni Med Health Sci. 2012; 11(1): 11-14


Role of Topiramate in Improving Quality of Life in Migraine Sufferers versus Gold Standard Propranolol

M. Jamil Laghari, Nasrin Qazi, Shanawaz Jamali, Ghulam Mustafa.


Abstract

OBJECT: To assess the role of Topiramate in reducing migraine related disability and improvement
in quality of life in migraine sufferers comparing with conventionally used drug propranolol.
BACKGROUND: Epilepsy and migraine have some biological features in common; therefore antiepileptic
drugs are suppose to be effective in migraine prophylaxis beside active treatment, in
reducing migraine headache attacks and therefore can improve sufferersÂ’ quality of life.
METHODS: Seventy diagnosed patients of migraine were enrolled in the study and 64 completed
the whole study period (12 weeks). They were divided in two groups: A (Topiramate) and
B (Propanolol). MIDAS scores were observed at day-0 and day-90 and results were statistically
analyzed.
RESULTS: Group received Topiramate showed better response and overall reduction was
62.51% (P-value

Key words: Migraine, Prophylaxis, Topiramate, Propranolol, MIDAS(Migraine Disability Assessment)






Full-text options


Share this Article



Online Article Submission
• ejmanager.com







eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.